Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ocuphire Pharma
AddedFeb 19, 2024
UpdatedJun 18, 2026
Ocuphire Pharma

Ocuphire Pharma

Public

US-based Ocuphire Pharma, Inc. develops and commercializes global therapies for various eye disorders.

HQ
Farmington Hills, MI, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for various eye disorders. Based in Farmington Hills, United States, the company aims to address unmet needs in ophthalmology through innovative treatments. Their research and development efforts target a range of ocular conditions, with the goal of improving patient outcomes globally.

The company has made significant progress in advancing its pipeline, as evidenced by its presentations at prestigious scientific conferences such as the ARVO Annual Meeting. Ocuphire Pharma's lead candidate, APX3330, has garnered attention in the ophthalmology community, indicating potential breakthroughs in eye disorder treatments. The company's participation in investor conferences also suggests growing interest from the financial sector in its developments.

Ocuphire Pharma - Similar Companies

Ocumension Therapeutics logo

Ocumension Therapeutics

OcuCure Therapeutics logo

OcuCure Therapeutics

EyePoint logo

EyePoint

Ocular Therapeutix logo

Ocular Therapeutix

ocutx.com

Visiox logo

Visiox

visioxpharma.com

Zhaoke Ophthalmology Pharmaceutical logo

Zhaoke Ophthalmology Pharmaceutical

Surface Pharmaceuticals logo

Surface Pharmaceuticals

surfacepharma.com

Eye-Pharma logo

Eye-Pharma

MediPrint Ophthalmics logo

MediPrint Ophthalmics

Concours Pharmaceuticals logo

Concours Pharmaceuticals

Outpost Medicine logo

Outpost Medicine

Iacta Pharmaceuticals logo

Iacta Pharmaceuticals

Lumos Pharma logo

Lumos Pharma

lumos-pharma.com

Apexian Pharmaceuticals logo

Apexian Pharmaceuticals

apexianpharma.com

Ocudyne logo

Ocudyne

ocudyne.com

Ocuphire Pharma - Quick Facts

Who are Ocuphire Pharma's competitors?

Companies similar to Ocuphire Pharma include Ocumension Therapeutics, OcuCure Therapeutics, EyePoint and Ocular Therapeutix.

When was Ocuphire Pharma founded?

Ocuphire Pharma was founded in 2018.

Where is Ocuphire Pharma's headquarters located?

Ocuphire Pharma's headquarters is located in Farmington Hills, MI, US.

When was Ocuphire Pharma's last funding round?

Ocuphire Pharma's most recent funding round was for $15M (USD) in June 2021.

How much has Ocuphire Pharma raised to-date?

As of Jun 8, 2021, Ocuphire Pharma has raised a total of $24.6M (USD).

How many employees does Ocuphire Pharma have?

Ocuphire Pharma has 8 employees as of Feb 6, 2024.

Ocuphire Pharma - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 23 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 510000Information
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 512000Motion Picture and Sound Recording Industries
  • 623000Nursing and Residential Care Facilities
  • 512100Motion Picture and Video Industries
  • 325410Pharmaceutical and Medicine Manufacturing
  • 512110Motion Picture and Video Production
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 6000Depository Institutions
  • 7800Motion Pictures
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 7810Motion Picture Production And Allied Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7812Motion Picture And Video Tape Production
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 5911Motion picture, video and television programme production activities